Regulation of V-ATPase assembly and function of V-ATPases in tumor cell invasiveness

Biochimica et Biophysica Acta - Bioenergetics

Volumn 1857, Issue 8, 2016, Pages 1213-1218

  McGuire, Christina ^a   Cotter, Kristina ^a   Stransky, Laura ^a   Forgac, Michael ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE; AMINO ACID; UNCLASSIFIED DRUG; V ATPASE; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; MECHANISTIC TARGET OF RAPAMYCIN COMPLEX 1; MULTIPROTEIN COMPLEX; PROTEIN SUBUNIT; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; RAS PROTEIN; TARGET OF RAPAMYCIN KINASE;

ARTICLE; BREAST CANCER CELL LINE; CANCER CELL; CELL INVASION; CELL MEMBRANE; CELL MIGRATION; CELL SURVIVAL; CONCENTRATION (PARAMETERS); DENDRITIC CELL; ENZYME REGULATION; FEMALE; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; IN VITRO STUDY; METASTASIS; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN EXPRESSION; PROTEIN FUNCTION; CELL MOTION; EPITHELIUM CELL; GENE EXPRESSION REGULATION; GENETICS; MAMMARY GLAND; METABOLISM; PATHOLOGY; PROTEIN SUBUNIT; SACCHAROMYCES CEREVISIAE; SIGNAL TRANSDUCTION; TUMOR CELL LINE; TUMOR INVASION;

CELL LINE, TUMOR; CELL MOVEMENT; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; EPITHELIAL CELLS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MAMMARY GLANDS, HUMAN; MULTIPROTEIN COMPLEXES; NEOPLASM INVASIVENESS; PROTEIN SUBUNITS; RAS PROTEINS; SACCHAROMYCES CEREVISIAE; SIGNAL TRANSDUCTION; TOR SERINE-THREONINE KINASES; VACUOLAR PROTON-TRANSLOCATING ATPASES;

EID: 84959279060     PISSN: 00052728     EISSN: 18792650     Source Type: Journal    
DOI: 10.1016/j.bbabio.2016.02.010     Document Type: Article

References (55)

1. [1] Cotter, K., Stransky, L., McGuire, C., Forgac, M., Recent Insights into the structure, regulation, and function of the V-ATPases. Trends Biochem. Sci. 40 (2015), 611–622, 10.1016/j.tibs.2015.08.005.
2. [2] Forgac, M., Vacuolar ATPases: rotary proton pumps in physiology and pathophysiology. Nat. Rev. Mol. Cell Biol. 8 (2007), 917–929, 10.1038/nrm2272.
3. [3] Kane, P.M., The long physiological reach of the yeast vacuolar H +-ATPase. J. Bioenerg. Biomembr. 39 (2007), 415–421, 10.1007/s10863-007-9112-z.
4. [4] Breton, S., Brown, D., Regulation of luminal acidification by the V-ATPase. Physiology 28 (2013), 318–329, 10.1152/physiol.00007.2013.
5. [5] Sun-Wada, G.-H., Wada, Y., Vacuolar-type proton pump ATPases: acidification and pathological relationships. Histol. Histopathol. 28 (2013), 805–815.
6. [6] Gruenberg, J., van der Goot, F.G., Mechanisms of pathogen entry through the endosomal compartments. Nat. Rev. Mol. Cell Biol. 7 (2006), 495–504, 10.1038/nrm1959.
7. [7] Couoh-Cardel, S., Milgrom, E., Wilkens, S., Affinity purification and structural features of the yeast vacuolar ATPase Vo membrane sector. J. Biol. Chem. 290 (2015), 27959–27971 jbc.M115.662494. doi:10.1074/jbc.M115.662494.
8. [8] Arai, H., Berne, M., Forgac, M., Inhibition of the coated vesicle proton pump and labeling of a 17,000-dalton polypeptide by N,N′-dicyclohexylcarbodiimide. J. Biol. Chem. 262 (1987), 11006–11011.
9. [9] Toei, M., Toei, S., Forgac, M., Definition of membrane topology and identification of residues important for transport in subunit a of the vacuolar ATPase. J. Biol. Chem. 286 (2011), 35176–35186, 10.1074/jbc.M111.273409.
10. [10] Kawasaki-Nishi, S., Nishi, T., Forgac, M., Arg-735 of the 100-kDa subunit a of the yeast V-ATPase is essential for proton translocation. Proc. Natl. Acad. Sci. 98 (2001), 12397–12402, 10.1073/pnas.221291798.
11. [11] Zhao, J., Benlekbir, S., Rubinstein, J.L., Electron cryomicroscopy observation of rotational states in a eukaryotic V-ATPase. Nature 521 (2015), 241–245, 10.1038/nature14365.
12. [12] Oot, R.A., Wilkens, S., Subunit interactions at the V1-Vo interface in yeast vacuolar ATPase. J. Biol. Chem. 287 (2012), 13396–13406, 10.1074/jbc.M112.343962.
13. [13] Bond, S., Forgac, M., The Ras/cAMP/protein kinase A pathway regulates glucose-dependent Assembly of the vacuolar (H +)-ATPase in yeast. J. Biol. Chem. 283 (2008), 36513–36521, 10.1074/jbc.M805232200.
14. [14] Liberman, R., Bond, S., Shainheit, M.G., Stadecker, M.J., Forgac, M., Regulated assembly of vacuolar ATPase is increased during cluster disruption-induced maturation of dendritic cells through a phosphatidylinositol 3-kinase/mTOR-dependent pathway. J. Biol. Chem. 289 (2014), 1355–1363, 10.1074/jbc.M113.524561.
15. [15] Stransky, L.A., Forgac, M., Amino acid availability modulates vacuolar H +-ATPase assembly. J. Biol. Chem. 290 (2015), 27360–27369, 10.1074/jbc.M115.659128.
16. [16] Toyomura, T., Murata, Y., Yamamoto, A., Oka, T., Sun-Wada, G.-H., Wada, Y., et al. From lysosomes to the plasma membrane: localization of vacuolar-type H +-ATPase with the a3 isoform during osteoclast differentiation. J. Biol. Chem. 278 (2003), 22023–22030, 10.1074/jbc.M302436200.
17. [17] Capecci, J., Forgac, M., The function of vacuolar ATPase (V-ATPase) a subunit isoforms in invasiveness of MCF10a and MCF10CA1a human breast cancer cells. J. Biol. Chem. 288 (2013), 32731–32741, 10.1074/jbc.M113.503771.
18. [18] Hinton, A., Sennoune, S.R., Bond, S., Fang, M., Reuveni, M., Sahagian, G.G., et al. Function of a subunit isoforms of the V-ATPase in pH homeostasis and in vitro invasion of MDA-MB231 human breast cancer cells. J. Biol. Chem. 284 (2009), 16400–16408, 10.1074/jbc.M901201200.
19. [19] Cotter, K., Capecci, J., Sennoune, S., Huss, M., Maier, M., Martinez-Zaguilan, R., et al. Activity of plasma membrane V-ATPases is critical for the invasion of MDA-MB231 breast cancer cells. J. Biol. Chem. 290 (2015), 3680–3692, 10.1074/jbc.M114.611210.
20. [20] von Schwarzenberg, K., Wiedmann, R.M., Oak, P., Schulz, S., Zischka, H., Wanner, G., et al. Mode of cell death induction by pharmacological vacuolar H +-ATPase (V-ATPase) inhibition. J. Biol. Chem. 288 (2013), 1385–1396, 10.1074/jbc.M112.412007.
21. [21] Sennoune, S.R., Luo, D., Martínez-Zaguilán, R., Plasmalemmal vacuolar-type H +-ATPase in cancer biology. Cell Biochem. Biophys. 40 (2004), 185–206, 10.1385/CBB:40:2:185.
22. [22] Hinton, A., Bond, S., Forgac, M., V-ATPase functions in normal and disease processes, Pflüg. Arch. Eur. J. Physiol. 457 (2009), 589–598, 10.1007/s00424-007-0382-4.
23. [23] Kane, P.M., Disassembly and reassembly of the yeast vacuolar H(+)-ATPase in vivo. J. Biol. Chem. 270 (1995), 17025–17032.
24. [24] Smardon, A.M., Nasab, N.D., Tarsio, M., Diakov, T.T., Kane, P.M., Molecular interactions and cellular itinerary of the yeast RAVE (Regulator of the H +-ATPase of vacuolar and endosomal membranes) complex. J. Biol. Chem. 290 (2015), 27511–27523, 10.1074/jbc.M115.667634.
25. [25] Smardon, A.M., Diab, H.I., Tarsio, M., Diakov, T.T., Nasab, N.D., West, R.W., et al. The RAVE complex is an isoform-specific V-ATPase assembly factor in yeast. Mol. Biol. Cell 25 (2014), 356–367, 10.1091/mbc.E13-05-0231.
26. [26] Lu, M., Ammar, D., Ives, H., Albrecht, F., Gluck, S.L., Physical interaction between aldolase and vacuolar H +-ATPase is essential for the assembly and activity of the proton pump. J. Biol. Chem. 282 (2007), 24495–24503, 10.1074/jbc.M702598200.
27. [27] Li, S.C., Diakov, T.T., Xu, T., Tarsio, M., Zhu, W., Couoh-Cardel, S., et al. The signaling lipid PI(3,5)P2 stabilizes V1-Vo sector interactions and activates the V-ATPase. Mol. Biol. Cell 25 (2014), 1251–1262, 10.1091/mbc.E13-10-0563.
28. [28] Xu, T., Forgac, M., Microtubules are involved in glucose-dependent dissociation of the yeast vacuolar [H +]-ATPase in vivo. J. Biol. Chem. 276 (2001), 24855–24861, 10.1074/jbc.M100637200.
29. [29] Parra, K.J., Kane, P.M., Reversible association between the V1 and V0 domains of yeast vacuolar H +-ATPase is an unconventional glucose-induced effect. Mol. Cell. Biol. 18 (1998), 7064–7074.
30. [30] Shao, E., Forgac, M., Involvement of the nonhomologous region of subunit A of the yeast V-ATPase in coupling and in vivo dissociation. J. Biol. Chem. 279 (2004), 48663–48670, 10.1074/jbc.M408278200.
31. [31] Kawasaki-Nishi, S., Nishi, T., Forgac, M., Yeast V-ATPase complexes containing different isoforms of the 100-kDa a-subunit differ in coupling efficiency and in vivo dissociation. J. Biol. Chem. 276 (2001), 17941–17948, 10.1074/jbc.M010790200.
32. [32] Dechant, R., Binda, M., Lee, S.S., Pelet, S., Winderickx, J., Peter, M., Cytosolic pH is a second messenger for glucose and regulates the PKA pathway through V-ATPase. EMBO J. 29 (2010), 2515–2526, 10.1038/emboj.2010.138.
33. [33] Banchereau, J., Briere, F., Caux, C., Davoust, J., Lebecque, S., Liu, Y.J., et al. Immunobiology of dendritic cells. Annu. Rev. Immunol. 18 (2000), 767–811, 10.1146/annurev.immunol.18.1.767.
34. [34] Trombetta, E.S., Ebersold, M., Garrett, W., Pypaert, M., Mellman, I., Activation of lysosomal function during dendritic cell maturation. Science 299 (2003), 1400–1403, 10.1126/science.1080106.
35. [35] Jiang, A., Bloom, O., Ono, S., Cui, W., Unternaehrer, J., Jiang, S., et al. Disruption of E-cadherin-mediated adhesion induces a functionally distinct pathway of dendritic cell maturation. Immunity 27 (2007), 610–624, 10.1016/j.immuni.2007.08.015.
36. [36] Vander Lugt, B., Beck, Z.T., Fuhlbrigge, R.C., Hacohen, N., Campbell, J.J., Boes, M., TGF-β suppresses β-catenin-dependent tolerogenic activation program in dendritic cells. PLoS One, 6, 2011, e20099, 10.1371/journal.pone.0020099.
37. [37] Merkulova, M., Păunescu, T.G., Azroyan, A., Marshansky, V., Breton, S., Brown, D., Mapping the H + (V)-ATPase interactome: identification of proteins involved in trafficking, folding, assembly and phosphorylation. Sci. Rep., 5, 2015, 14827, 10.1038/srep14827.
38. [38] Laplante, M., Sabatini, D.M., mTOR Signaling in growth control and disease. Cell 149 (2012), 274–293, 10.1016/j.cell.2012.03.017.
39. [39] Zoncu, R., Bar-Peled, L., Efeyan, A., Wang, S., Sancak, Y., Sabatini, D.M., mTORC1 senses lysosomal amino acids through an inside-out mechanism that requires the vacuolar H(+)-ATPase. Science 334 (2011), 678–683, 10.1126/science.1207056.
40. [40] Sautin, Y.Y., Lu, M., Gaugler, A., Zhang, L., Gluck, S.L., Phosphatidylinositol 3-kinase-mediated effects of glucose on vacuolar H +-ATPase assembly, translocation, and acidification of intracellular compartments in renal epithelial cells. Mol. Cell. Biol. 25 (2005), 575–589, 10.1128/MCB.25.2.575-589.2005.
41. [41] Kohio, H.P., Adamson, A.L., Glycolytic control of vacuolar-type ATPase activity: a mechanism to regulate influenza viral infection. Virology 444 (2013), 301–309, 10.1016/j.virol.2013.06.026.
42. [42] Marjuki, H., Gornitzky, A., Marathe, B.M., Ilyushina, N.A., Aldridge, J.R., Desai, G., et al. Influenza A virus-induced early activation of ERK and PI3K mediates V-ATPase-dependent intracellular pH change required for fusion: ERK and PI3K regulate V-ATPase activity. Cell. Microbiol. 13 (2011), 587–601, 10.1111/j.1462-5822.2010.01556.x.
43. [43] Zhang, C.-S., Jiang, B., Li, M., Zhu, M., Peng, Y., Zhang, Y.-L., et al. The lysosomal v-ATPase-ragulator complex is a common activator for AMPK and mTORC1, acting as a switch between catabolism and anabolism. Cell Metab. 20 (2014), 526–540, 10.1016/j.cmet.2014.06.014.
44. [44] Sennoune, S.R., Bakunts, K., Martínez, G.M., Chua-Tuan, J.L., Kebir, Y., Attaya, M.N., et al. Vacuolar H +-ATPase in human breast cancer cells with distinct metastatic potential: distribution and functional activity. Am. J. Physiol. Cell Physiol. 286 (2004), C1443–C1452, 10.1152/ajpcell.00407.2003.
45. [45] Soule, H.D., Maloney, T.M., Wolman, S.R., Peterson, W.D., Brenz, R., McGrath, C.M., et al. Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10. Cancer Res. 50 (1990), 6075–6086.
46. [46] Santner, S.J., Dawson, P.J., Tait, L., Soule, H.D., Eliason, J., Mohamed, A.N., et al. Malignant MCF10CA1 cell lines derived from premalignant human breast epithelial MCF10AT cells. Breast Cancer Res. Treat. 65 (2001), 101–110.
47. [47] Tognon, E., Kobia, F., Busi, I., Fumagalli, A., De Masi, F., Vaccari, T., Control of Lysosomal Biogenesis and Notch-dependent Tissue Patterning by Components of the TFEB-V-ATPase Axis in Drosophila melanogaster, Autophagy. 2016 (Epub ahead of print. doi: 10.1080/15548627.2015.1134080).
48. [48] Perera, R.M., Stoykova, S., Nicolay, B.N., Ross, K.N., Fitamant, J., Boukhali, M., et al. Transcriptional control of autophagy-lysosome function drives pancreatic cancer metabolism. Nature 524 (2015), 361–365, 10.1038/nature14587.
49. [49] Mason, S.D., Joyce, J.A., Proteolytic networks in cancer. Trends Cell Biol. 21 (2011), 228–237, 10.1016/j.tcb.2010.12.002.
50. [50] Mohamed, M.M., Sloane, B.F., Cysteine cathepsins: multifunctional enzymes in cancer. Nat. Rev. Cancer 6 (2006), 764–775, 10.1038/nrc1949.
51. [51] Rothberg, J.M., Bailey, K.M., Wojtkowiak, J.W., Ben-Nun, Y., Bogyo, M., Weber, E., et al. Acid-mediated tumor proteolysis: contribution of cysteine cathepsins. Neoplasia 15 (2013), 1125–1137.
52. [52] Victor, B.C., Anbalagan, A., Mohamed, M.M., Sloane, B.F., Cavallo-Medved, D., Inhibition of cathepsin B activity attenuates extracellular matrix degradation and inflammatory breast cancer invasion. Breast Cancer Res., 13, 2011, R115, 10.1186/bcr3058.
53. [53] Turk, V., Turk, B., Guncar, G., Turk, D., Kos, J., Lysosomal cathepsins: structure, role in antigen processing and presentation, and cancer. Adv. Enzym. Regul. 42 (2002), 285–303.
54. [54] Webb, B.A., Chimenti, M., Jacobson, M.P., Barber, D.L., Dysregulated pH: a perfect storm for cancer progression. Nat. Rev. Cancer 11 (2011), 671–677, 10.1038/nrc3110.
55. +-ATPase promotes distant metastasis in the mouse B16 melanoma cells. Mol. Cancer Res. 9 (2011), 845–855, 10.1158/1541-7786.MCR-10-0449.